Epygenix
Clinical trials sponsored by Epygenix, explained in plain language.
-
New drug hopes to tame rare seizure disorder in kids and adults
Disease control Recruiting nowThis study tests an experimental drug called EPX-100 (clemizole hydrochloride) as an add-on treatment for people with Dravet syndrome, a rare and severe form of epilepsy. About 150 children and adults aged 2 and older will receive either the drug or a placebo for 20 weeks. The ma…
Phase: PHASE3 • Sponsor: Epygenix • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New hope for hard-to-treat seizures: experimental drug enters final testing phase
Disease control Recruiting nowThis study tests whether an experimental drug called clemizole HCl can help reduce seizures in people with Lennox-Gastaut syndrome, a severe form of epilepsy that often starts in childhood. About 260 children and adults aged 2 to 55 will receive either the drug or a placebo along…
Phase: PHASE3 • Sponsor: Epygenix • Aim: Disease control
Last updated May 07, 2026 18:38 UTC